iBio, Inc. (IBIO)
2.41
-0.40
(-14.23%)
USD |
NASDAQ |
Dec 11, 16:00
2.41
0.00 (0.00%)
After-Hours: 18:31
iBio EPS Diluted (Quarterly): -0.108 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Minerva Neurosciences, Inc. | -0.3625 |
| Bionano Genomics, Inc. | -1.593 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.72M |
| Revenue (Quarterly) | 0.10M |
| Total Expenses (Quarterly) | 5.82M |
| Enterprise Value | 16.92M |
| Gross Profit Margin (Quarterly) | -189.0% |
| Profit Margin (Quarterly) | -5.72K% |
| Earnings Yield | -57.81% |
| Normalized Earnings Yield | -57.81 |